Medscape

Patient Preferences Drive Treatment for Allergic Rhinitis

Patients with pollen-related allergic rhinitis prefer on demand antihistamines, with treatment preferences differing markedly ...
Healio

Allergic Rhinitis Treatment in Primary Care: Non-Drowsy Options for Symptom Relief

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients with allergic rhinitis (AR), misdiagnosis ...
Business Wire

Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal ...

Neurent Medical Raises EUR62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK(R) Commercial Expansion to treat Chronic Rhinitis

"I am delighted to welcome MVM Partners and Sofinnova Partners to the Neurent Medical team, two global leaders in medtech investing," said CEO of Neurent Medical, Brian Shields. "This Series C ...
Healio

Q&A: Wearable device uses acoustic resonance to treat nasal congestion

Please provide your email address to receive an email when new articles are posted on . SONU is an at-home nonpharmaceutical treatment that uses acoustic resonance therapy. The device operates as a ...
MassDevice

Neurent Medical reports positive findings for Neuromark chronic rhinitis device

Neurent Medical today announced positive findings from a randomized controlled trial evaluating its Neuromark system.
Yahoo Finance

Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis

GALWAY, Ireland and BRAINTREE, Mass., Feb. 11, 2026 /PRNewswire/ -- Neurent Medical, the pioneer behind NEUROMARK ®, an innovative, minimally invasive solution to treat chronic rhinitis, today ...